The Shift to Home Infusion Therapy: A Transformative Trend in Healthcare and M&A
The Shift to Home Infusion Therapy: A Transformative Trend in Healthcare and M&A
Healthcare is evolving, with a significant shift from hospital-based treatments to home-based care. Home infusion therapy, which involves administering medications like chemotherapy, antibiotics, and biologics at home, is at the forefront of this transformation. This change is not only enhancing patient comfort and reducing healthcare costs but is also driving a surge in mergers and acquisitions (M&A) within the home infusion sector.
The Rise of Home Infusion Therapy
Home infusion therapy allows patients to receive treatments in the comfort of their homes, offering several advantages:
Cost Efficiency: Home-based care is often more cost-effective than hospital admissions, reducing overhead and facility fees.
Patient Comfort: Receiving treatment at home allows patients to remain in a familiar environment, which can improve overall satisfaction and quality of life.
Reduced Risk of Hospital-Acquired Infections: Home care minimizes exposure to hospital settings, thereby reducing the risk of infections.
Advancements in Medical Technology: Innovations in portable infusion devices and telehealth monitoring have made home infusion therapy more feasible and safe.
According to Grand View Research, the global home infusion therapy market was valued at USD 38.66 billion in 2024 and is expected to reach USD 61.72 billion by 2030, growing at a CAGR of 8.2%. (Grand View Research) In the U.S., the market is projected to grow from USD 21.08 billion in 2025 to USD 38.02 billion by 2032, exhibiting a CAGR of 8.8%. (Fortune Business Insights)
Chemotherapy at Home: A Case Study
Chemotherapy, once exclusively administered in hospitals, is increasingly being delivered at home. Studies have shown that patients receiving chemotherapy at home report high levels of satisfaction and lower rates of treatment discontinuation. For instance, a study published in the Journal of Clinical Oncology found that patients receiving home-based chemotherapy experienced fewer side effects and had a better quality of life compared to those receiving treatment in a hospital setting.
This shift not only benefits patients but also healthcare providers. Hospitals and clinics can reduce overcrowding and allocate resources more efficiently, while home infusion providers can expand their services and reach a broader patient population.
M&A Activity in the Home Infusion Sector
The growth of home infusion therapy has attracted significant interest from private equity firms and other investors. These investors are keen on acquiring home infusion providers to capitalize on the expanding market and the recurring revenue models associated with home-based care.
Recent M&A activity in the home infusion sector includes:
KabaFusion's Acquisition of Coram's Infusion Care Assets: In May 2025, KabaFusion, a nationally recognized leader in home and alternative site infusion, acquired Coram's infusion care assets, expanding its national footprint and enhancing its service offerings.
RF Investment Partners' Majority Investment in Valley Vital: In January 2025, RF Investment Partners announced a majority investment in Valley Vital, a leading franchisee within the Vital Care Infusion Services franchise system, operating infusion therapy pharmacies across Virginia and West Virginia.
Dynamic Infusion's Acquisition of Infusicare: In July 2024, Dynamic Infusion acquired IV Solutions Group, d/b/a Infusicare, strengthening its presence in New Jersey and aligning with its goal of building a national platform for home infusion nursing services.
These transactions highlight the growing interest and investment in the home infusion sector, driven by the increasing demand for home-based care and the potential for scalable business models.
Strategic Considerations for Providers
For home infusion providers considering entering the M&A market, several strategic considerations are paramount:
Building Strong Relationships with Specialty Pharmacies: Establishing and maintaining robust partnerships with specialty pharmacies can enhance service delivery and patient satisfaction, making providers more attractive to potential investors.
Ensuring Regulatory Compliance: Adhering to healthcare regulations and maintaining accreditation standards are crucial for operational success and for instilling confidence in investors.
Leveraging Technology: Implementing advanced technologies for patient monitoring and data management can improve care quality and operational efficiency, adding value to the business.
Demonstrating Financial Stability: Maintaining strong financial health and a clear growth trajectory can make a provider more appealing to potential acquirers.
The Role of Thought Leaders in the M&A Process
Industry experts and advisors play a crucial role in guiding home infusion providers through the complexities of the M&A process. Professionals with experience in healthcare mergers and acquisitions can offer valuable insights into market trends, valuation metrics, and strategic positioning. Their expertise can help providers navigate negotiations, identify potential buyers or acquisition targets, and ensure that transactions align with long-term business objectives.
Conclusion
The shift towards home infusion therapy represents a significant evolution in healthcare delivery, offering benefits to patients, providers, and investors alike. As the market continues to grow, driven by advancements in medical technology and changing patient preferences, the home infusion sector presents lucrative opportunities for strategic investments and acquisitions.
For providers looking to navigate this dynamic landscape, collaborating with experienced professionals can provide the expertise and support needed to capitalize on emerging opportunities and achieve sustainable growth.
Whats Next?
If you're a home infusion provider considering strategic options or seeking to understand market dynamics, reach out to experienced advisors in the field. With a wealth of experience in healthcare M&A and a focus on the home infusion sector, these professionals can provide tailored advice and support to help you achieve your business objectives.
Jake@acquire.care
